Search results
S2 Episode 5: Epidemiology of RSV in Adults
Medscape· 3 days agoFor more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Forest W....
Measles cases have been reported in 19 states this year. What does a measles rash look like?
The Today Show via AOL· 5 days agoEarly stage In the early stage of the illness, measles share symptoms with common childhood...
Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant ...
Benzinga· 3 days agoBeyfortus real-world evidence published in The Lancet shows 82% reduction in infant RSV hospitalizations New real-world evidence shows Beyfortus (nirsevimab) substantially ...
Magazine: Anticipation rises for RSV rollout as positive data emerges
Pharmaceutical Technology via Yahoo Finance· 4 days agoIn this issue: Following the RSV therapy and vaccine rollout, understanding molecular glues, using...
Moderna expects CDC to view its RSV vaccine as equal to rival shots
Reuters· 3 days ago, opens new tab said on Thursday it expects U.S. Center for Disease Control and Prevention (CDC)...
What’s Going Around: Seasonal allergies, strep throat, influenza, stomach viruses, COVID
ClickOnDetroit· 3 days agoHere’s our weekly round-up of what illnesses are spreading the most in Metro Detroit communities,...
Moderna Stock Jumps After Scoring an Earnings Beat. Next Up? Its RSV Shot.
Barrons.com· 3 days agoModerna reported first-quarter financial results Thursday that soundly beat Wall Street...
Moderna to seek parity for RSV shot (NASDAQ:MRNA)
Seeking Alpha· 3 days agoModerna (MRNA) stock gains as the company highlights its upcoming RSV shot, expecting the U.S. regulators to endorse it on par with rival products. Read more here.
Moderna Breaks Out For The First Time In A Year After Covid Shot Wallops Sales Views
Investor's Business Daily· 3 days agoThe company hopes to win Food and Drug Administration approval for its RSV vaccine. RSV, the...
Moderna Focused on Cutting Costs, RSV Vaccine
Bloomberg· 3 days agoModerna Chief Executive Officer Stéphane Bancel talks about how the biotech giant is cutting costs and developing new vaccines. The drugmaker expects to...